Literature DB >> 25117545

fadD deletion and fadL overexpression in Escherichia coli increase hydroxy long-chain fatty acid productivity.

Jin H Bae1, Beom Gi Park, Eunok Jung, Pyung-Gang Lee, Byung-Gee Kim.   

Abstract

A major problem of long-chain fatty acid (LCFA) hydroxylation using Escherichia coli is that FadD (long-chain fatty acyl-CoA synthetase), which is necessary for exogenous LCFA transport, also initiates cellular consumption of LCFA. In this study, an effective method to prevent the cellular consumption of LCFA without impairing its transport is proposed. The main idea is that a heterologous enzyme which consumes LCFA can replace FadD in LCFA transport. For the model heterologous enzyme, CYP153A from Marinobacter aquaeolei, which converts palmitic acid into ω-hydroxy palmitic acid, was expressed in E. coli. When fadD was deleted from an E. coli strain, CYP153A indeed maintained the ability to transport LCFA. A disadvantage of fadD deletion mutant is the fact that FadD deficiency downregulates the transcription of fadL (outer membrane LCFA transporter) via FadR (fatty acid metabolism regulator protein), was solved by fadL overexpression from a plasmid. In addition, the overexpression of fadL was able to offset catabolite repression on fadL, allowing glucose to be used as the primary carbon source. In conclusion, the strain with fadD deletion and fadL overexpression showed 5.5-fold increase in productivity compared to the wild-type strain, converting 2.6 g/L (10.0 mM) of palmitic acid into 2.4 g/L (8.8 mM) of ω-hydroxy palmitic acid in a shake flask. This simple genetic manipulation can be applied to any LCFA hydroxylation using E. coli.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25117545     DOI: 10.1007/s00253-014-5974-2

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  8 in total

1.  Hydrolase BioH knockout in E. coli enables efficient fatty acid methyl ester bioprocessing.

Authors:  Marvin Kadisch; Andreas Schmid; Bruno Bühler
Journal:  J Ind Microbiol Biotechnol       Date:  2016-12-24       Impact factor: 3.346

Review 2.  Overview of the Cellular Stress Responses Involved in Fatty Acid Overproduction in E. coli.

Authors:  Neha Sawant; Harinder Singh; Deepti Appukuttan
Journal:  Mol Biotechnol       Date:  2021-11-18       Impact factor: 2.695

3.  P212A Mutant of Dihydrodaidzein Reductase Enhances (S)-Equol Production and Enantioselectivity in a Recombinant Escherichia coli Whole-Cell Reaction System.

Authors:  Pyung-Gang Lee; Joonwon Kim; Eun-Jung Kim; EunOk Jung; Bishnu Prasad Pandey; Byung-Gee Kim
Journal:  Appl Environ Microbiol       Date:  2016-01-22       Impact factor: 4.792

4.  Improving Escherichia coli membrane integrity and fatty acid production by expression tuning of FadL and OmpF.

Authors:  Zaigao Tan; William Black; Jong Moon Yoon; Jacqueline V Shanks; Laura R Jarboe
Journal:  Microb Cell Fact       Date:  2017-02-28       Impact factor: 5.328

5.  Biosynthesis of Medium-Chain ω-Hydroxy Fatty Acids by AlkBGT of Pseudomonas putida GPo1 With Native FadL in Engineered Escherichia coli.

Authors:  Qiaofei He; George N Bennett; Ka-Yiu San; Hui Wu
Journal:  Front Bioeng Biotechnol       Date:  2019-10-17

6.  Enhanced production of iturin A by strengthening fatty acid synthesis modules in Bacillus amyloliquefaciens.

Authors:  Lin Gao; Menglin She; Jiao Shi; Dongbo Cai; Dong Wang; Min Xiong; Guoming Shen; Jiaming Gao; Min Zhang; Zhifan Yang; Shouwen Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-09-09

7.  Metabolic engineering of Escherichia coli for the production of hydroxy fatty acids from glucose.

Authors:  Yujin Cao; Tao Cheng; Guang Zhao; Wei Niu; Jiantao Guo; Mo Xian; Huizhou Liu
Journal:  BMC Biotechnol       Date:  2016-03-08       Impact factor: 2.563

8.  Engineering of CYP153A33 With Enhanced Ratio of Hydroxylation to Overoxidation Activity in Whole-Cell Biotransformation of Medium-Chain 1-Alkanols.

Authors:  Hyuna Park; Doyeong Bak; Wooyoung Jeon; Minjung Jang; Jung-Oh Ahn; Kwon-Young Choi
Journal:  Front Bioeng Biotechnol       Date:  2022-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.